InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the complete record of transactions filed by Burek Julie, Chief Financial Officer. Director active across 1 companies, notably Voyager Therapeutics, Inc.. Cumulatively, 9 disclosures have been published. Total volume traded: €23k. The latest transaction was disclosed on 21 March 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€19,6532,618 shares@ €7.50690.0085% mcap55.2% of flow
Common Stock
SEC:0001104659-22-037151:0·
€2,462789 shares@ €3.12080.0011% mcap6.9% of flow
Common Stock
SEC:0001104659-22-025669:0·
€1,063361 shares@ €2.94340.0005% mcap3.0% of flow
Common Stock
SEC:0001104659-22-023833:0·
010,000 shares0
Common Stock
SEC:0001104659-22-005023·
010,000 shares0
Common Stock
SEC:0001104659-22-005023:0·
€6,2213,063 shares@ €2.0309100.0% of flow
Common Stock
SEC:0001104659-22-004515·
€6,2213,063 shares@ €2.03090.0027% mcap17.5% of flow
Common Stock
SEC:0001104659-22-004515:0·
013,500 shares0
Common Stock
SEC:0001104659-21-144995·
013,500 shares0
Common Stock
SEC:0001104659-21-144995:0·
9 of 9 declarations
About Burek Julie
Julie Burek is Vice President and Chief Financial Officer at Voyager Therapeutics, Inc. She oversees the company's financial operations and is responsible for financial planning and risk management. Her expertise is crucial in ensuring the financial health of the company.
